Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parathyroid Function Assessment by Indocyanine Green Fluorescence After Total Thyroidectomy
2019-003506-26Phase 4Active
- Sponsor
- Hospital Universitari Son Espases
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in hypocalcemia and hypoparathyroidism, sponsored by Hospital Universitari Son Espases. Primary endpoint: Serum calcium level at 24 hours postoperatively. Started Jan 2020; status: active.
02
Drugs
indocyanine green
03
Conditions
hypocalcemiahypoparathyroidism
Beyond the preview
Go deeper on 2019-003506-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003506-26.